Furthermore, ratios of biofluid markers can also discriminate PSP from healthy controls with higher levels of Glial Fibrillary Acidic Protein (GFAP)/t-tau and NfL/t-tau in CSF and plasma and lower levels of GFAP/NfL in CSF.49 The gene discussed is NEFL; the disease is supranuclear palsy, progressive, 1.